home.aspx
 
EVENTS

2nd Middle East Pharmacy and Pharmaceutical Conference
2ND MIDDLE EAST PHARMACY AND PHARMACEUTICAL CONFERENCE
December 09-10, 2019
The 2nd Middle east Pharmacy and Pharmaceutical Conference will be held amid December 09-10, 2019 at Dubai, UAE.  Pharma Conference 2019 is a worldwide stage for drug specialists, pharmaceutical advertising professional's, pharmaceutical industry experts, and analysts, researchers, clinicia...

SiriusDecisions 2019 Technology Exchange
SIRIUSDECISIONS 2019 TECHNOLOGY EXCHANGE
December 09-11, 2019
The drive for growth never ceases for b-to-b organizations, and more than ever technology is at the centre of enabling that progress. Gone are the days however when a disparate, disconnected set of platforms strewn across sales, marketing an product can serve the organization effectively. An aligned...

Advantia Health

Advantia Health is an innovative fast growing healthcare delivery company, founded and led by a passionate group of entrepreneurs and backed by top tier healthcare investors. Sean Glass, Founder & CEO of Advantia Health, previously founded and grew a financial technology company to more than a billion dollar valuation. Advantia Health provides high quality, high value care using technology and highly efficient outpatient facilities. In a little over three years, the company has grown to serve more than 100,000 customers and is on a path to serving many more in the years to come. Advantia’s investors include Deerfield Management, Life Force Capital, and individuals with significant health care, technology, and finance expertise.

RELATED NEWS


NHS England has unveiled detailed proposals of how prescriptions for “ineffective, over-priced and low value treatments” will be cut in order to shave millions off of the NHS’ drugs bill. A public consultation has now been launched on new national guidelines blocking 18 treatments which together cost taxpayers £141 million a year, including homeopathy, which NHS chief executive Simon Stevens describes as “at best a placebo and a misuse of scarce NHS funds”. The consultation also covers a further...

READ MORE

Scientists have developed and validated a blood test for Alzheimer’s disease, with the potential to massively ramp up the pace of Alzheimer’s disease drug trials. Scientists have teamed up to develop and validate a blood test for Alzheimer’s disease, with the potential to massively ramp up the pace of Alzheimer’s disease drug trials. The blood test measures a specific peptide in the blood to inform scientists, with 90 percent accuracy, if a patient has the very earliest s...
EUROPEAN PHARMACEUTICAL REVIEW
READ MORE

A massive hike in the use proton pump inhibitors among older Australians over the past couple of decades is finally tapering off, according to new data. Between 1995 and 2006, prescriptions.....
PHARMACYNEWS.COM.
READ MORE

AmpliPhi Biosciences  Corporation (“AmpliPhi”) (NYSE American: APHB), a clinical-stage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, and C3J Therapeutics, Inc. (“C3J”), a private clinical stage biotechnology company focused on the development of novel targeted antimicrobials, today announced that the companies have entered into a definitive agreement under which a wholly owned su...

READ MORE

AstraZeneca and Merck & Co., Inc., (Merck; known as MSD outside of the US and Canada) today announced that they have entered a global strategic oncology collaboration to co-develop and co-commercialise AstraZeneca's Lynparza (olaparib) for multiple cancer types. Lynparza is an innovative, first-in-class oral poly ADP ribose polymerase (PARP) inhibitor currently approved for BRCA-mutated ovarian cancer in multiple lines of treatment. Lynparza's pipeline has grown significantly in the last few yea...

READ MORE

The pharma industry saw double-digit growth in patent filings for the second year in a row in 2018, with applications from the UK up by a fifth, according to the latest data released by the European Patent Office (EPO). There were 7,441 filings in the pharmaceutical category throughout 2018, up from 6,534 in 2017 – a 13.9% increase. This marks the second consecutive year of double-digit growth in pharmaceutical filings at the EPO, with the sector has increased by 11.7% last year. Filings i...

READ MORE

EVENTS

2nd Middle East Pharmacy and Pharmaceutical Conference
2ND MIDDLE EAST PHARMACY AND PHARMACEUTICAL CONFERENCE
December 09-10, 2019
The 2nd Middle east Pharmacy and Pharmaceutical Conference will be held amid December 09-10, 2019 at Dubai, UAE.  Pharma Conference 2019 is a worldwide stage for drug specialists, pharmaceutical advertising professional's, pharmaceutical industry experts, and analysts, researchers, clinicia...

BIOFIT 2019
BIOFIT 2019
December 10-11, 2019
With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming fro...